Trimethylcolchicinic acid methyl ether
From DrugPedia: A Wikipedia for Drug discovery
(→Description) |
(→External Links) |
||
Line 74: | Line 74: | ||
[http://crdd.osdd.net/raghava/biadb/detail.php?id=2115 Link to BIAdb Database] | [http://crdd.osdd.net/raghava/biadb/detail.php?id=2115 Link to BIAdb Database] | ||
+ | [[Category:BIAdb]] |
Revision as of 11:07, 10 December 2009
Trimethylcolchicinic acid methyl ether
| |
Systematic (IUPAC) name | |
(7S)-7-amino-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[g]heptalen-9-one; (2R,3R)-2,3-dihydroxybutanedioicacid | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
ChemSpider | |
Chemical data | |
Formula | C24H29NO11 |
Mol. mass | 507.48716 |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Contents |
Description
RN given refers to (S)-isomer; synonyms NSC-36354 and TMCA refers to tartrate [1:1]
A colchicine analog with potential antineoplastic activity. Trimethylcolchicinic acid binds to tubulin, inhibiting its polymerization into microtubules and preventing cell division.
General Properties
*Molecular Weight
507.48716
*Molecular Formula
C24H29NO11
*IUPAC NAME
(7S)-7-amino-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[g]heptalen-9-one; (2R,3R)-2,3-dihydroxybutanedioicacid
*Canonical Smiles
COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)N.C(C(C(=O)O)O)(C(=O)O)O
*Isomeric Smiles
COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(=C(C(=C32)OC)OC)OC)N.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
*XLogP
N/A
*Topological Polar Surface Area
195
Toxicity
organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 parenteral 9500ug/kg (9.5mg/kg) Progress in Medical Chemistry. Vol. 9, Pg. 1, 1973.
human TDLo oral 200ug/kg/7D-I (0.2mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING,BLOOD: LEUKOPENIA,BLOOD: THROMBOCYTOPENIA Cancer Chemotherapy Reports, Part 1. Vol. 56, Pg. 263, 1972.
mouse LD50 intraperitoneal 70520ug/kg (70.52mg/kg) National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 parenteral 8mg/kg (8mg/kg) Progress in Medical Chemistry. Vol. 9, Pg. 1, 1973.
rat LD50 parenteral 3mg/kg (3mg/kg) Progress in Medical Chemistry. Vol. 9, Pg. 1, 1973.